Recobia Therapeutics

Is developing an innovative platform of biocompatible, biodegradable polysaccharide-based hydrocolloid gels for the controlled subcutaneous release of therapeutic antibodies and ADCs. This approach aims to make biological cancer treatments more accessible by facilitating rapid, convenient subcutaneous administration for patients and hospitals.